证券记录 · 已归档季度
GSK
GSK plc · Healthcare · Drug Manufacturers - General
17被追踪持有人
+1Δ持有人
220.73M持有股份
$8.48B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +6.2% ·
股份流向 +0.3% ·
净新建仓位 +5.9%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 163.18K | $7.64M | n/a | n/a |
| Q2 2026 | 115 | +1 | 291.71M | $15.16B | +8 | −8 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | n/a |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | n/a | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | n/a | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | n/a |
| Q2 2024 | 12 | n/a | 118.47M | $4.56B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 78.76M | +0.1% | $3.02B | 1.7% | ▲ Add | 5 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 61.00M | n/a | $2.34B | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 3 | Fisher Asset Management ✦ | 31.34M | +4.3% | $1.20B | 0.5% | ▲ Add | 5 | SEC ↗ |
| 4 | PRIMECAP Management ✦ | 27.73M | +7.8% | $1.06B | 0.8% | ▲ Add | 5 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 8.05M | +4.2% | $308.98M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (被动) | 6.71M | -3.7% | $260.79M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 2.25M | +13.6% | $86.43M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 1.60M | n/a | $61.60M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 9 | Wellington Management ✦ | 1.45M | -24.1% | $55.86M | 0.0% | ▼ Trim | 5 | SEC ↗ ×6 |
| 10 | Bridgewater Associates ✦ | 1.34M | +11.7% | $51.61M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 121.69K | -92.5% | $4.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 89.50K | 0.0% | $3.44M | 0.0% | Held | 4 | SEC ↗ |
| 13 | Tweedy, Browne ✦ | 86.87K | -4.1% | $3.34M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 14 | Millennium Management ✦ | 78.43K | +168.7% | $3.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Norges Bank ✦ (被动) | 55.00K | 新增 | $2.11M | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 53.29K | +32.4% | $2.05M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | Adage Capital Partners ✦ | 8.97K | 新增 | $344,333 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Norges Bank | $2.11M | 0.0% |
| Adage Capital Partners | $344,333 | 0.0% |
已清仓
| Arrowstreet Capital | $57.86M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,022 持有人, 373.63M 股份, $18.86B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据